Detection and characterization of primary liver cancer in rats by MS-264-enhanced MRI

Magnetic Resonance in Medicine

Volumn 35, Issue 4, 1996, Pages 532-539

  Petré, Carine ^a   Ni, Yicheng ^a   Marchal, Guy ^a,c   Yu, Jie ^a   Wevers, Martine ^a   Lauffer, Randall B ^b   Baert, Albert L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Metasyn Inc   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cancer; Contrast agent; Liver; Magnetic resonance imaging

Indexed keywords

DISEASES; LIVER; MAGNETIC RESONANCE IMAGING; RATS; TUMORS;

ABDOMINAL ORGANS; CANCER; CONTRAST AGENT; CONTRAST ENHANCEMENT; HEPATOCELLULAR CARCINOMA; INTRAVENOUS ADMINISTRATION; MR CONTRAST AGENTS; PRIMARY LIVER CANCERS;

IMAGE ENHANCEMENT;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INFILTRATION; CONTRAST ENHANCEMENT; HEPATOBILIARY DISEASE; IMAGE ENHANCEMENT; LIVER CANCER; MICROANGIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

EID: 0029925922     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910350412     Document Type: Article

References (26)

1. J. T. Ferruci, MR Imaging of the liver. Am. J. Roentgenol. 147, 1103-1116 (1986).
2. 2-weighted SE imaging-lesion detection, localization and characterization. Radiology 190(3), 727-736 (1994).
3. 2-weighted fat suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5T. Radiology 184(3), 687-694 (1992).
4. R. F. Thoeni. Imaging of the liver. Curr. Opin. Radiol. 4(3), 44-53 (1992).
5. B. Hamm, The value of magnetic resonance tomography in the detection and differential diagnosis of focal liver lesions. Radiologe 32(5), 232-240 (1992).
6. G. Marchal, X. Zhang, Y. Ni, P. Van Hecke, J. Yu, A. L. Baert, Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Magn. Reson. Imaging 11, 665-674 (1993).
7. D. G. Mitchell, D. D. Stark, Liver, in "Magnetic Resonance Imaging." 2nd ed., pp. 1670-1676, Mosby. St. Louis, 1992.
8. G. Schuhmann-Giampieri, Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. Invest Radiol. 28(8), 753-761 (1993).
9. P. Reimer, E. J. Rummeny, B. Hamm, A. Mühler, F. Cavagna, S. Saini, P. E. Peters, Fortschritte in der Magnetresonanztomographie der Leber: Bedeutung ultraschneller Bildgebung und Leberspezifischer Kontrastmittel. Bildgebung 61, 5-13 (1994).
10. E. J. Rummeny, P. E. Peters, Stand und Entwicklung neuer klinischer Kontrastmittel für die MR-Diagnostik von Lebererkrankungen. Radiologe 32, 225-231 (1992).
11. R. B. Lauffer, D. J. Parmelee, B. G. Jenkins, D. M. Scott, P. J. Bernard, Z. Tyeklar, G. E. Heinig, T. J. McMurry, H. Sajiki, H. S. Quellet, R. C. Walovitch, Liver enhancement in normal and tumor-bearing rats with MS-264, a new high-relaxivity hepatobiliary agent, in "Proc., SMR, 2nd Annual Meeting, 1994," p. 1513.
12. D. J. Parmalee, R. C. Walovitch, H. S. Quellet, B. G. Jenkins, R. B. Lauffer, Mechanistic studies of the liver agent MS-264 in rat models of hepatobiliary dysfunction, in " Proc., SMR, 3rd Annual Meeting, 1995," p. 173.
13. R. C. Walovitch, T. J. McMurry, Z. Tyeklar, D. M. Scott, P. J. Bernard, D. J. Parmalee, H. S. Quellet, S. Vallabhajosula, R. B. Lauffer, Biodistribution and safety studies of MS-264, a new liver agent with hepatobiliary specificity, in "Proc., SMR, 2nd Annual Meeting, 1994," p. 387.
14. G. M. Wogan, The induction of liver cell cancer by chemicals, in "Liver Cell Cancer" (H. M. Cameron, D. A. Linsell, G. P. Warwick, Eds.), pp. 121-152, Elsevier, Amsterdam, Holland, 1976.
15. H. A. Edmondson, P. E. Steiner, Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7, 462-503 (1954).
16. R. K. Zeman, A. Dritschilo, P. M. Silverman, L. R. Clark, B. S. Garra, D. S. Thomas, J. D. Ahlgren, F. P. Smith, S. M. Korec, R. J. Nauta, J. S. Dillon, Dynamic CT versus 0.5 T MR imaging in the detection of surgically proven hepatic metastases. J. Comput. Assist. Tomogr. 13(4), 637-644 (1989).
17. K. Wernecke, E. Rummeny, G. Bongartz, P. Vassallo, D. Kivelitz, W. Wiesman, P. E. Peters, B. Reers, M. Reiser, W. Pircher, Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. Am. J. Roentgenol. 157, 731-739 (1991).
18. B. A. Ward, D. L. Miller, J. A. Frank, A. J. Dwyer, J. T. Simmons, R. Chang, T. H. Shawker, P. Choyke, A. E. Chang, Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery 105(2), 180-187 (1989).
19. R. A. Malt, Current concepts: surgery for hepatic neoplasms. N. Engl. J. Med. 313(25), 1591-1596 (1985).
20. M. A. Adson, Surgery symposium: mass lesions of the liver, Mayo Clin. Proc. 61(5), 362-367 (1986).
21. D. G. Mitchell, Hepatic imaging: techniques and unique applications of magnetic resonance imaging. Magn. Reson. Q. 9(2), 84-112 (1993).
22. T. J. Vogl, B. Hamm, B. Schnell, B. Eibl-Eibesfeldt. S. Steiner, J. Lissner, The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver. RÖFO 155(6), 568-574 (1991).
23. B. Van Beers, R. Demeure, J. Pringot, D. Defalque, A. Geubel, J. F. Gigot, J. Jamart, Dynamic spin-echo imaging with Gd-DTPA: value in the differentiation of hepatic tumors. Am. J. Roentgenol. 154(3), 515-519 (1990).
24. Y. Ni, G. Marchai, J. Yu, A. Mühler, G. Lukito, A. L. Baert, Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. J. Magn. Reson. Imaging 4, 355-363 (1994).
25. Y. Ni, G. Marchai, J. Yu, E. Rummeny, X. Zhang, K. P. Lodemann, A. L. Baert, Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. Radiology 188, 45-51 (1993).
26. Y. Kondo, T. Nakajima, Pseudoglandular hepatocellular carcinoma. Cancer 60, 1032-1037 (1987).